Lecault Veronique has filed 8 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 539265 shares of AbCellera Biologics Inc. ($ABCL) on January 01, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Technology Officer | A | Share option (right to buy) | 539265 | $0.00 | 5,201,069.0000 | 298,875,174 | 11.57% | 0.18% |
| Jan. 1, 2025 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Operating Officer | A | Share option (right to buy) | 832033 | $0.00 | 4,661,804.0000 | 294,327,532 | 21.73% | 0.28% |
| June 21, 2024 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Operating Officer | M | Share option (right to buy) | 83334 | $0.00 | 3,829,771.0000 | 289,166,486 | 2.13% | 0.03% |
| June 21, 2024 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Operating Officer | M | Common Shares | 83334 | $0.19 | 9,613,674.0000 | 289,166,486 | 0.87% | 0.03% |
| Jan. 14, 2024 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Operating Officer | A | Share option (right to buy) | 770416 | $0.00 | 3,913,105.0000 | 289,166,486 | 24.51% | 0.27% |
| Sept. 12, 2023 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Operating Officer | P | Common Shares | 20000 | $5.19 | 9,530,340.0000 | 314,827,255 | 0.21% | 0.01% |
| May 5, 2023 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Operating Officer | M | Common Shares | 250000 | $0.19 | 9,510,340.0000 | 314,827,255 | 2.70% | 0.08% |
| May 5, 2023 | AbCellera Biologics Inc. | $ABCL | Lecault Veronique | Chief Operating Officer | M | Share option (right to buy) | 250000 | $0.00 | 3,142,689.0000 | 314,827,255 | 7.37% | 0.08% |